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Ca
2þ transfer from endoplasmic reticulum (ER) to mitochondria can trigger apoptotic pathways by inducing release of
mitochondrialpro-apoptoticfactors.Threedifferenttypesofinositol1,4,5-trisphosphatereceptor(IP3R)servetodischargeCa
2þ
from ER, but possess some peculiarities, especially in apoptosis induction. The anti-apoptotic protein Akt can phosphorylate all
IP3R isoforms and protect cells from apoptosis, reducing ER Ca
2þ release. However, it has not been elucidated which IP3R
subtypes mediate these effects. Here, we show that Akt activation in COS7 cells, which lack of IP3R I, strongly suppresses
IP3-mediated Ca
2þ release and apoptosis. Conversely, in SH-SY 5Y cells, which are type III-deﬁcient, Akt is unable to modulate
ER Ca
2þ ﬂux, losing its anti-apoptotic activity. In SH-SY 5Y-expressing subtype III, Akt recovers its protective function on cell
death, by reduction of Ca
2þ release. Moreover, regulating Ca
2þ ﬂux to mitochondria, Akt maintains the mitochondrial integrity
and delays the trigger of apoptosis, in a type III-dependent mechanism. These results demonstrate a speciﬁc activity of Akt on
IP3R III, leading to diminished Ca
2þ transfer to mitochondria and protection from apoptosis, suggesting an additional level of
cell death regulation mediated by Akt.
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Ca
2þ efﬂux from intracellular stores, in particular endoplas-
mic reticulum (ER), has a fundamental role in modulating
different cellular responses. Variations of Ca
2þ concentration
[Ca
2þ] works as a trigger, for example, for the secretion of
hormones and neurotransmitters, modulation of metabolism
and mitotic division in numerous cell types.
1 Several extra-
cellularstimuliinduceERdepletion,withconsequentcytosolic
Ca
2þ increase, through activation of phospholipase C, which
leads to the production of a second messenger, inositol 1,4,5-
trisphosphate(IP3).IP3inturnactivatesaninternalmembrane
receptor, responsible for ER Ca
2þ release, the IP3 receptor
(IP3R). In birds and mammals, three different genes encode
for three subtypes of IP3R (IP3R I, II and III), which share high
similarity (70–80%) in their primary sequences and are
expressed to varying degrees in individual cell types. Despite
their analogy, the three subtypes possess some peculiarities,
which characterize and distinguish them, such as subcellular
localization, modulation by binding proteins and kinases,
degradation by proteases and regulation by small molecules
(i.e., Ca
2þ and ATP).
2 Phosphorylation/dephosphorylation
events regulate IP3Rs Ca
2þ release and these modiﬁcations
assume particular relevance in cell death.
3 In fact, it is now
generally accepted that Ca
2þ ﬂux from the ER and
consequent high levels of mitochondrial Ca
2þ accumulation
– a cationic transfer favored by the physical interconnection
betweenthetwoorganelles
4–islinkedtotheeffectsofseveral
apoptotic stimuli; ER Ca
2þ release is therefore considered an
intrinsic mechanism thatfavors apoptosis.
5,6 Various pro/anti-
apoptotic proteins interact with IP3R and modulate ER Ca
2þ
dynamics to exert their activity: one of these is the anti-
apoptotic protein Akt. The proto-oncogene Akt (also known as
protein kinase B) is involved in several cellular processes
such as glucose metabolism, cell proliferation, apoptosis,
transcription and cell migration.
7 Akt is a serine/threonine
kinase and it is the major downstream target of receptor
tyrosine kinases that signal via the phosphoinositide 3-kinase
(PI3K). Receptor-activated PI3K leads to membrane attach-
ment and subsequent phosphorylation and activation of Akt.
8
Activated Akt exerts its pro-survival activity through phos-
phorylation of target proteins, inhibiting their pro-apoptotic
function.
9 All three subtypes of IP3R present, in their
C-terminal tail, a robust phosphorylation motif RXRXX(S/T),
highly conserved in different species,
10 which is a substrate
forAktkinaseactivity.
10,11Bothgroupscited,usingmutantsof
type I IP3Rs, declared that IP3R phosphorylation by Akt
promotes survival, but only the work of Roderick’s group
11
connected it to an inhibition of ER Ca
2þ release. We
demonstrated that Akt activation protects cells from apoptosis
by strongly reducing Ca
2þ ﬂux from the ER.
12
Here, we report a thorough analysis of Akt anti-apoptotic
activity through the regulation of IP3RC a
2þ channels. Using
cells that display different ratios of IP3Rs, we show that Akt
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www.nature.com/cddisfunctions speciﬁcally on IP3R isoform III, independently of the
presence or absence of isoform I. Finally, our data highlight
how the Akt-dependent inhibition of Ca
2þ transfer from the
ER to mitochondria, through IP3R III, preserves the mitochon-
drial integrity and protects from Ca
2þ-mediated apoptosis.
Results
We previously reported that Akt protects from Ca
2þ-depen-
dent apoptotic stimuli through inhibition of ER Ca
2þ releasein
HeLa cells.
12 To investigate whether Akt might possess a
potential functional role on a speciﬁc isoform of IP3R, we used
two different cell lines, COS7 and SH-SY 5Y, which lack IP3R
type I
13 and type III,
14 respectively. After conﬁrmation of the
effective suitability of our cellular systems (Figure 1a), we
measured intracellular calcium homeostasis using aequorin
probes, targeted to different subcellular compartments, that
is, the cytoplasm and the organelles acting as sources (ER) or
targets (mitochondria) of the Ca
2þ signal. We compared
mock-transfected (control) with myristoylated/palmytolated
Akt (m/p-Akt)-overexpressing cells, where m/p-Akt is a
plasma membrane-targeted Akt chimera, considered a con-
stitutively active form.
15 In COS7 cells, Akt affects neither the
total ER Ca
2þ content (317.67±15.75mM control versus
288.33±25.96mM m/p-Akt) nor the kinetics of Ca
2þ accu-
mulation. After stimulation with ATP (which functions on Gq-
coupled plasma membrane receptors and causes the
production of IP3, thus releasing Ca
2þ from the ER through
the IP3Rs), Akt-overexpressing cells display a very different
behavior in the release phase (Figure 1b), with an
86,7±1.9% decrease in the Vmax of released Ca
2þ (Vmax:
14.32±2.11mM/s control versus 1.9±0.27mM/s m/p-Akt).
Conversely, in SH-SY 5Y cells, the inhibition of ER Ca
2þ
release mediated by Akt overexpression is negligible
(Figure 1c), with no signiﬁcative differences in the ER plateau
values (329.46±11.09mM control versus 308.25±11.18mM
m/p-Akt), similarly to COS7 cells, and a tiny reduction in the
[Ca
2þ] ﬂow through the IP3-gated channels (Vmax:
19.39±0.97mM/s control versus 17.49±1.34mM/s m/p-Akt).
We used Carbachol (Cch) as agonist stimulus instead of ATP
in SH-SY 5Y cells, because in this cell type, Cch generates
higher ER Ca
2þ release than ATP (data not shown).
The close physical association between ER and mitochon-
dria
4explainshowmitochondriadetecttheCa
2þ ﬂuxreleased
by ER very efﬁciently. Using an aequorin form targeted to the
mitochondrial matrix, we measured mitochondrial [Ca
2þ]
in COS7 and SH-SY 5Y cells, to have a further read-out
system of Akt activity on IP3RC a
2þ-releasing properties.
As expected, in COS7 cells, Akt overexpression markedly
reduces Ca
2þ transient in the mitochondrial compartment
(11.89±1.31mM control versus 1.42±0.06mM m/p-Akt;
Figure 1d); this is owing to the IP3R inhibition described
above. Figure 1e shows how, in SH-SY 5Y cells, Akt activity
does not alter mitochondrial Ca
2þ homeostasis in any
marked manner, compared with COS7 (peak amplitude:
32.33±4.23mM control versus 27.34±2.17mM m/p-Akt),
conﬁrming the weak reticular Akt action on Ca
2þ release
in this cell type. To complete the scenario, we analyzed
the cytosolic Ca
2þ kinetics: in Akt-transfected COS7 cells,
the [Ca
2þ] increases evoked by stimulation with ATP are
signiﬁcantly smaller than in controls (peak amplitude:
0.8±0.017mM versus 1.72±0.027mM; Figure 1f), whereas
in SH-SY 5Y this reduction is almost undetectable
(peak amplitude: 1.45±0.051mM versus 1.83±0.064mM;
Figure 1g).
Having shown the very different effect of Akt expression on
the modulation of calcium homeostasis in COS7 and SH-SY
5Y cells, we sought to examine the rate of apoptosis after
treatment with a Ca
2þ-mediated apoptotic stimulus. IP3Ri s
an important molecular component regulating apoptosis
induced by a number of different stimuli, and IP3R-mediated
Ca
2þ releasecanactivateapoptoticpathwaysbyinducingthe
release of a number of pro-apoptotic factors from mitochon-
dria.
5 As apoptosis inducer we used arachidonic acid (AA), a
very speciﬁc stimulus that triggers Ca
2þ-dependent cell
death.
16 In neuronal and non-neuronal cell lines, AA leads
to apoptosis via a mitochondrial-mediated pathway,
17,18
opening the mitochondrial permeability transition pore, with
consequent release of cytochrome c, followed by activation of
caspase 3-dependent nuclear condensation and fragmenta-
tion. In COS7 cells, Akt overexpression protects from
apoptosis induced by AA, with a marked reduction of the
amount of cleaved poly-ADP-ribosomal polymerase (PARP)
and caspase 3 (Figure 2a, lanes 1 and 4). Moreover, these
data were conﬁrmed by direct measurements of caspase
activity after application of AA, showing a signiﬁcant decrease
of caspase 3 activity in m/p-Akt-overexpressing cells
(Figure 2b). In SH-SY 5Y cells, the Akt anti-apoptotic effect
seems to be lost: in fact, no differences were detected both in
cleaved PARP levels and in the amount of cleaved caspase3,
comparing control and m/p-Akt-expressing cells after AA
treatment(Figure 2c). Similarresults are showedin Figure 2d,
where AA induces an increase in caspase 3 activity which is
mostly comparable between control and m/p-Akt-overexpres-
sing SH-SY 5Y. This assay becomes necessary for a correct
visualization of the real caspase 3 activity, because of the
difﬁculty in the detection of cleaved form of the enzyme by
immunoblotting in this cellular type.
To assess if the protective role of Akt in COS7 cells may be
ascribed to a minor amount of reticular Ca
2þ released, we
analyzed the kinetics of cytosolic Ca
2þ generated by AA
application. Given that the increase in cytosolic [Ca
2þ]
([Ca
2þ]c) evoked by apoptotic stimuli is in the nanomolar
range, the [Ca
2þ]c was measured with the ﬂuorescent
indicator Fura-2/AM,
19 as aequorin is not accurate enough
to reveal small arises of [Ca
2þ]. We performed a cotransfec-
tion (in a 1:1 ratio) using green ﬂuorescent protein with a
mitochondrial presequence (mtGFP) and m/p-Akt, to identify
Akt-positive cells and, therefore, to compare changes in Fura-
2/AM 340/380 ratio on the same coverslip. Thus, GFP-
positive cells were distinguished from controls by the typical
ﬂuorescence emitted upon illumination with blue light. AA
addition causes a cytosolic Ca
2þ increment that is signiﬁ-
cantly reduced in Akt-expressing cells (Figure 3a, red trace),
with a reduction of 47.8%. Parallel experiments were performed
in SH-SY 5Y (Figure 3b), but in these cells m/p-Akt over-
expression does not alter the amount of cytosolic Ca
2þ evoked
by AA application (blue trace). This result is in perfect agree-
ment with the weak Akt activity at the reticular level (Figure 1c)
and its lack of anti-apoptotic function (Figures 2c and d).
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Cell Death and DiseaseMitochondrial fragmentation is one of early events that
occur in apoptotic pathway, it is evolutionarily conserved,
20
and it represents a clear hallmark of mitochondrial perturba-
tion, which precedes effector caspase activation and cell
death.
21 We investigated if the Ca
2þ transfer from ER to
mitochondria promoted by AA might lead to fragmentation of
theorganelleandifAkt,modulatingERcalciumrelease,might
preserve the mitochondrial integrity, minimizing the apoptotic
damage. First of all, we used HeLa cells not only because
thesecellsexpressmostlytypeIandIIIIP3R,withnodetected
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Figure 1 Akt-modulation of the Ca
2þ signal in COS7, but not in SH-SY 5Y cells. (a)I P 3R levels in COS7, HeLa and SH-SY 5Y cells. HeLa cells were used as reference
because they possess both type I and III IP3Rs; the increment of p-Akt S473 levels reﬂects an effective Akt activation after m/p-Akt overexpression. (b)E RC a
2þ
measurements in mock-transfected and m/p-Akt-overexpressing COS7 cells. To induce Ca
2þ release from ER, cells were challenged with ATP, an agonist that, through
interactionwithG-protein-coupledreceptors,evokesarapiddischargefromIP3Rs.AktactivationmarkedlymodulatesERCa
2þ kinetics(redtrace),diminishingtheamountof
Ca
2þ released,quantiﬁedafteranalysisofmaximumrateofcalciumreleaseduringagoniststimulation(seebarsinsidethedottedcircle).(c)Experimentsanalogoustobwere
carried out in SH-SY 5Y cells. In these cells, the agonist used is Cch. (d) Mitochondrial Ca
2þ homeostasis modulation after Akt activation in COS7 cells and (e) in SH-SY 5Y
cells. (f) Cytosolic Ca
2þ homeostasis in control and m/p-Akt-overexpressing COS7 and (g) SH-SY 5Y cells. Where indicated, cells were stimulated with 100mM ATP or
500mM Cch. The bars in d–g indicate the levels of Ca
2þ uptake, expressed in percentage, control assumed as 100%. All traces are from single representative experiments
and [Ca
2þ] are presented as means of at least 20 experiments (±S.E.)
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Cell Death and Diseaselevels of subtype II,
13 but mainly because it is a well-
characterized cellular system in which it has been shown that
Akt carries out its anti-apoptotic role.
11,12 To ensure the
overexpression of the protein of interest in all observed
mitochondrial networks, we co-transfected cells with the
indicated vector (empty vector for control cells) and mtGFP
in a 3:1 ratio. Figure 4 in toto shows mitochondrial structures
of different cells before and 20min after treatment with AA;
this duration of time reﬂects the maximum peak of cytosolic
Ca
2þ released by the ER. AA induces a robust mitochondrial
fragmentation (Figure 4a), whereas only minor changes in
morphology were detected in m/p-Akt-overexpressing HeLa
cells (Figure 4b). Analogously, in COS7 cells, AA application
leads to fragmentation of the organelle (Figure 4c) and Akt
expression preserved the three-dimensional mitochondrial
integrity (Figure 4d). On the contrary, on SH-SY 5Y cells, no
effect of m/p-Akt was detected, with similar morphological
modiﬁcationsbothincontrolandAkt-expressingcells(Figures
4e and f), once more revealing the Akt inability to exert its
‘usual’ anti-apoptotic activity in this cellular setting. Mathe-
matical description of mitochondrial fragmentation is reported
in Figure 4g.
We wanted to explore whether the huge discrepancy in Akt
behavior between COS7 and SH-SY 5Y might be due to the
IP3R isoform III deﬁciency, which characterizes the latter
cellular type. To demonstrate our hypothesis, we used a
speciﬁc kind of SH-SY 5Y (herein referred as SH 2) that
expresses IP3R III (Figure 5a).
22 First of all, we analyzed the
ER kinetics, with particular attention to the release phase.
After agonist induction, m/p-Akt-overexpressing SH 2 cells
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Figure 2 Akt protects from Ca
2þ-dependent apoptosis in COS7, but not in SH-SY 5Y cells. (a) COS7 cells were transfected with the indicated gene (control: mock-
transfected), harvested after 36h, and the endogenous cleavages of PARP and caspase 3 were revealed through immunoblotting. Apoptosis was induced by treatment with
80mM AAfor40min.(b)COS7cells weretransfectedandtreatedinthesamemannerofa, aliquotsofcells werecentrifuged,andlysateswereassayedfor caspase3activity
as described in Materials and Methods. Traces are from a single representative experiment. (c) Immunoblotting showed different levels of cleaved PARP and caspase 3 in
SH-SY 5Y after apoptosis induction and m/p-Akt overexpression. control, mock transfected. (d) Similar experiment to b but performed in SH-SY 5Y cells. The experiments
were repeated at least ﬁve times
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Cell Death and Diseasedisplayed a signiﬁcant reduction in the rate of delivered Ca
2þ
(Vmax: 17.39±1.41mM/s control versus 9.73±1.62mM/s m/p-
Akt), keeping the ER Ca
2þ content unaffected (Figure 5b;
release phase magniﬁcation in inset). This inhibition of Ca
2þ
ﬂow through IP3Rs, mediated by Akt, is mirrored at the
mitochondrial level, with a marked decrease in mitochondrial
Ca
2þ uptake(peakamplitude:45.06±2.94mMcontrolversus
22.65±2.53mM m/p-Akt; Figure 5c). We note that this is a
very large difference in comparison with SH-SY 5Y IP3R III-
deﬁcient cells (Figure 1e). We then asked whether the
presence of isoform III of IP3R is the key point of Akt activity
on calcium-mediated apoptosis. We measured the intracel-
lular Ca
2þ levels after AA treatment in SH 2, using Fura-2/AM
as a probe: m/p-Akt overexpression produced minor changes
in the cytosolic Ca
2þ kinetics generated by AA (Figure 5d,
green trace), lowering the ability of arachidonate to increase
the intracellular [Ca
2þ]c. We wanted to directly correlate this
evidence with a putative ‘recovered’ Akt ability to protect from
apoptosis in SH 2 cells. In fact, Akt hyper-activation in SH 2
cells conferred a signiﬁcant resistance to AA-apoptosis
induction, expressed as caspase 3 activation levels
(Figure 5e). Also, immunoblotting revealed a minor amount
bothincleavedPARPandcaspase3(Figure5f),whichfurther
sustained the Akt role in signiﬁcantly reducing the apoptotic
Ca
2þ signals promoted by AA. We recorded the Akt capacity
to delay/block the transfer of Ca
2þ-death messages from ER
tomitochondriathroughanalysisofthemitochondrialnetwork.
AsFigure5gshows,nomorphologicalchangesweredetected
in Akt-expressing SH 2 cells, whereas AA induces mitochon-
drial ﬁssion in control cells, indicating how preservation of the
mitochondrial integrity under apoptotic stress is required for
correct Akt surviving activity.
Discussion
In this study, we have used different cell lines expressing
different subtypes of IP3R ratio, to understand if Akt may have
an IP3R isoform-speciﬁc action. Our work demonstrates that
Akt preferentially exerts its anti-apoptotic role through inhibi-
tionofCa
2þ releasebyIP3RtypeIII(Figure6),andSH-SY5Y
cells deﬁcient for this receptor isoform appear insensitive to
the typical Akt surviving activity (Figures 2c and d), showing
no differences in ER calcium release both after physiological
(Figure 1c) and apoptotic stimulation (Figure 3b). As
apoptosis inducer, we used AA: AA application causes a
progressive release of Ca
2þ from intracellular stores, thereby
directly causing a [Ca
2þ]c rise and activating capacitative
Ca
2þ inﬂux, which in turn is responsible for maintaining a
long-lasting [Ca
2þ]c plateau.
Interestingly, Akt protection from staurosporine-induced
celldeathinSH-SY5Yseemsduetothemitochondrialactivity
of the kinase.
23 Nevertheless, the predominant (93%)
endogenous IP3R isoform in COS7 cells has been reported
to be type III,
13 with no detectable levels of type I (Figure 1a).
In this cellular type, Akt shows its greater activity, with a
marked reduction of Ca
2þ released by ER after apoptotic
stimulus (Figure 3a) and protection from apoptosis (Figures
2a and b). The inhibition of Ca
2þ ﬂux after agonist stimulation
is more marked than previously observed in HeLa cells, an
aspect which may be ascribed to the amount of IP3R III in
COS7 cells. Moreover, in Sf9 insect cells Akt seems to
phosphorylate type III IP3R more efﬁciently than type I.
11
The preferential role of Akt on subtype III may be related to
the implicationsof thisisoform in avariety of Ca
2þ-dependent
physiological processes. For example, it promotes Ca
2þ-
dependent insulin and somatostatin secretion in pancreatic b
and d cells,
24 and it is localized to the apical pole of different
type of cells,
25,26 a region responsible for Ca
2þ signals
generation and thus termed ‘trigger zone’. These observa-
tions suggest that type III is more prone to initiate global
release of intracellular Ca
2þ in intact cells.
27 This is further
supported by the lack of Ca
2þ-dependent negative feedback
of IP3R III.
28 Intriguingly, it has been recently reported that the
phosphorylation of the receptor by Akt kinase is enhanced in
the presence of Ca
2þ,
29 and, considering the Akt inhibitory
effect on ER calcium release, it may represent an intrinsic
cellular mechanism to reinstate basal conditions, favoring ER
reﬁlling after store depletion due to agonist stimulation.
In a similar way to Akt, cAMP-dependent protein kinase
(PKA), another component belonging to the AGC kinase
group, is able to bind and phosphorylate all IP3Rs,
30 and type
III withacertainefﬁciency.
31PKA ishighlyhomologoustoAkt,
sharing B45% sequence identity with the kinase domain, and
rising to B80% within the ATP site. Subtype III is phosphory-
latedbyPKAatthreedifferentserineresidues,
31and,similarly
to Akt, a decrease in intracellular Ca
2þ release mediated by
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Figure 3 Akt modulates [Ca
2þ]c elevation generated by AA. (a) Effects of
m/p-Akt on [Ca
2þ]c increase induced by AA in COS7 or (b) in SH-SY 5Y cells.
Cells were loaded with the Ca
2þ indicator Fura-2/AM and the kinetics of the
[Ca
2þ]c response is presented as the ratio of ﬂuorescence at 340 and 380 nm.
The coverslips with the cells were maintained in 1mM Ca
2þ/KRB and, where
indicated, the cells were challenged with 80mM AA. To distinguish Akt-positive
cells and compare changes in the 340/380 Fura-2/AM ratio on the same coverslip,
cells were co-transfected with mtGFP and m/p-Akt in a 1:1 ratio. Traces are from a
single representative experiment. The data are the mean of different angular
coefﬁcients±S.E. of, at least, 15 independent experiments; the bars in the graph
show the change in percentage of cytosolic Ca
2þ released
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32 Conversely, an opposite role of PKA on
Ca
2þ mobilizationbyIP3RIIIhasbeenreported,
33suggesting
an alternative mechanism to justify the inhibition.
The most important aspect arising from our data refers
to apoptosis. Akt activation does not protect from Ca
2þ-
mediated cell death in cellslacking for IP3R III, a phenomenon
which cannot be considered cell-type dependent, because
SH-SY 5Y-expressing isoform III showed the typical Akt
surviving activity (Figure 5). This result can reasonably
be ascribed to a modiﬁcation in subtype III-Ca
2þ release
properties, altered by Akt (Figure 5d). As Akt, another
negative regulator of apoptosis, the Bcl-2 family member
+ AA
control m/p-Akt ab
c d
ef
HeLa
COS7
SH-SY 5Y
+ AA
+ AA
+ AA
+ AA
+ AA
0
30
60
90
120
150
180
0.1 0.3 0.5 0.7 0.9 1.1 0.1 0.3 0.5 0.7 0.9 1.1
0
30
60
90
120
150
180
210
0.1 0.3 0.5 0.7 0.9 1.1
0
25
50
75
125
100
C.F
.
C.F. C.F.
g
ν
ν
ν
control
control + AA
m/p Akt
m/p Akt + AA
SH-SY 5Y COS7 HeLa
Figure 4 Akt preserves the mitochondrial integrity in an IP3R type III-dependent way. (a–f) The mitochondrial network of HeLa (a and b), COS7 (c and d) and SH-SY 5Y
cells (e and f) was analyzed using confocal microscopy, 36h post-transfection, before and after treatment with 80mM AA for 20min. Cells were co-transfected in a 3:1 ratio
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Cell Death and DiseaseBcl-xL, seems to be able to interact with all three IP3R
isoforms,
34 though isoform-speciﬁc effects have been
described.
35 The association between Bcl-xL, amount of
ER Ca
2þ released and apoptosis is exclusively effective for
type III, because although all three IP3R isoforms provided
apoptosis resistance when expressed with Bcl-xL, only the
type III channel reduced ER [Ca
2þ].
35
The role of IP3R III in apoptosis is, currently, partially
controversial, and it is described both as an anti-
36 and a
pro-apoptotic protein.
37 We agree with the latter hypothesis,
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2þ celldeathinSH-SY5Y-expressingIP3RtypeIII. (a)Immunoblottingshowedtheeffectivepresenceof isoformIII of
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The insets show a greater magniﬁcation of the mitochondrial network
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Cell Death and Diseaseand we are strongly convinced that it is a key factor in
apoptosis, especially in Ca
2þ-dependent cell death: in fact,
siRNA silencing of IP3R III antagonizes apoptosis induced
by different Ca
2þ-mediated stimuli (P Pinton, unpublished
data). Further support to this concept is provided by the
evidence that, in CHO cells, subtype III co-localizes more
closely with mitochondria, and thus preferentially transmits
Ca
2þ signals to theseorganelles.
38 This observation explains
Akt ability to preserve the mitochondrial integrity (Figure 4),
delaying Ca
2þ transfer from the ER to mitochondria by
inhibition of type III channel gating. The Akt isoform-speciﬁc
activity completes the molecular pathway describing a new
role of promyelocytic leukemia (PML) protein as an apoptosis
regulator at the ER–mitochondria interface. PML controls
Ca
2þ transfer to mitochondria through the formation of a
complex that, besides PML, includes Akt, IP3R III and PP2A.
39
In conclusion, our data collectively suggest the existence of
a speciﬁc activity of Akt on IP3R type III, leading to channel
inhibition, diminished Ca
2þ transfer to mitochondria and
protectionfromapoptosis.Wesupposethatthefunctionofthe
kinase at the ER–mitochondria level is the early stage of Akt
itinerary in promoting cell survival, this concept is also
supported by the very recent observation about the reticular
localization of mTORC2, the complex responsible for Akt
phosphorylation and activation.
40 Thus, the modulation of
typeIII-Ca
2þ releasesuggestsanadditionallevelofcelldeath
regulation mediated by Akt.
Materials and Methods
Cell culture and transfection. HeLa cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS),
L-glutamine and penicillin/streptomycin in 75-cm
2 Falcon ﬂasks. Both kinds of
SH-SY 5Y cells (with and without IP3R III) were cultured in Ham’s nutrient mixture
F12 (HAM’S/F12), supplemented with 10% FCS, 2mM L-glutamine, penicillin/
streptomycin and MEM non-essential amino-acid solution (Sigma-Aldrich,
St. Louis, MO, USA), in 75-cm
2 Falcon ﬂasks.
For aequorin experiments, cells were seeded onto 13-mm glass coverslips
and allowed to grow to 75% conﬂuence; for Fura-2/AM measurements and
mitochondrial morphology analysis, cells were seeded on 24-mm glass coverslip
in the same conditions of growth.
For aequorin measurements in HeLa and COS7 cells, transfection with 4mg
of total DNA (3mg of the indicated expression plasmids and 1mg of aequorin)
transfected with a standard calcium–phosphate procedure. In both kinds of
SH-SY 5Y cells, we performed transfection with the same 3:1 DNA ratio, using
Lipofectamine LTX (Invitrogen-Life Technologies, Grand Island, NY, USA). All
measurements were performed 36h after transfection.
Aequorin measurements. Probes used are chimeric aequorins targeted to
the ER (erAEQmut), cytosol (cytAEQ) and mitochondria (mtAEQmut). ‘AEQ’ refers
to wild-type aequorin, and ‘AEQmut’ refers to a low-afﬁnity D119A mutant of
aequorin. For the experiments with cytAEQ and mtAEQmut, cells were incubated
with 5mM coelenterazine for 1–2h in DMEM supplemented with 1% FCS.
A coverslip with transfected cells was placed in a perfused thermostated chamber
located in close proximity to a low-noise photomultiplier with a built-in ampliﬁer/
discriminator. To reconstitute erAEQmut with high efﬁciency, the luminal [Ca
2þ]o f
the ER ﬁrst had to be reduced. This was achieved by incubating cells for 1h
at 41C in Krebs-Ringer buffer (KRB) supplemented with 5mM coelenterazine,
5mMC a
2þ ionophore ionomycin (Sigma-Aldrich) and 600mM EGTA. After this
incubation, cells were extensively washed with KRB supplemented with 2% bovine
serum albumin and then transferred to the perfusion chamber. All aequorin
measurements were carried out in KRB supplemented with either 1mM CaCl2
(cytAEQ and mtAEQmut) or 100mM EGTA (erAEQmut). Agonist was added to the
same medium as speciﬁed in ﬁgure legends. The experiments were terminated by
lysing cells with 100mM digitonin in a hypotonic Ca
2þ-containing solution (10mM
CaCl2 in H2O), thus discharging the remaining aequorin pool. The output of the
discriminator was captured by a Thorn EMI photon-counting board and stored in
an IBM-compatible computer for further analyses. The aequorin luminescence
data were calibrated ofﬂine into [Ca
2þ] values using a computer algorithm based
on the Ca
2þ response curve of wild-type and mutant aequorins.
IP R
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ER ER
Ca  release Ca  release
Resting condition Akt hyper-activation
IP R
type 3
Caspase 3
cleavage
[Ca ] Mitochondrial
Fragmentation
NO
Mitochondrial
Fragmentation
Caspase 3
cleavage
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Figure 6 Model depicting Akt anti-apoptotic activity through regulation of IP3R type III-Ca
2þ transfer to mitochondria. During basal condition, when Akt activation is
physiological, a Ca
2þ-dependent apoptotic stimulus evokes Ca
2þ release from the ER, especially through isoform III, with consequent mitochondrial Ca
2þ accumulation,
fragmentation of the network and apoptosis. In situations with enhanced Akt activity, a typical condition of many cancers, subtype III is inhibited, therefore decreasing the
amount of Ca
2þ accumulated by mitochondria. The mitochondrial network remains undamaged and apoptosis is blocked
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Cell Death and DiseaseFura-2/AM measurements. Cytosolic-free [Ca
2þ]c was evaluated using
ﬂuorescent Ca
2þ indicator Fura-2/AM (Molecular Probes-Life Technologies,
Grand Island, NY, USA). Brieﬂy, cells were incubated in medium supplemented
with 2.5mM Fura-2/AM for 30min, washed with KRB to remove extracellular
probe, supplied with preheated KRB (supplemented with 1mMCaCl2) and placed
in a thermostated incubation chamber at 371C on the stage of an inverted
ﬂuorescence microscope (Zeiss Axiovert 200, Carl Zeiss, Oberkochen, Germany).
Dynamic video imaging was performed using MetaFluor software (Universal
Imaging Corporation Ltd, Marlow, Buckinghamshire, UK). Fluorescence was
measured every 100ms with the excitation wavelength alternating between 340
and 380nm and the emission ﬂuorescence being recorded at 510nm. At the end
of the experiment, a region free of cells was selected, and one averaged
background frame was collected at each excitation wavelength for background
correction.
Caspase 3 assay. Cells were centrifuged (1000g for 5min) and washed once
in phosphate-buffered saline. The enzcheck caspase 3 assay kit # 2 by Molecular
Probes was used for the determination of caspase 3 activity. Lysate (20mg),
resuspended in a ﬁnal volume of 100ml, was assayed using Wallac 1420 Victor3
multitask plate reader (Perkin Elmer, Waltham, MA, USA).
Imaging and analysis of mitochondrial morphology. HeLa, Cos7
and SH-SY5Y cells were seeded and transfected with mtGFP as described
previously (see Results). Protein expression was allowed for 36h and then cells
where imaged with Nikon Swept Field Confocal (Nikon Instruments Inc., Melville,
NY, USA) equipped with CFI Plan Apo VC60XH objective (n.a. 1.4) and an Andor
DU885 EM-CCD camera (Andor, Belfast, Northern Ireland), controlled by the NIS-
Elements 3.2. Coverslips were placed in an incubated chamber with controlled
temperature, CO2 and humidity and then z-stacks were acquired by 21 planes with
0.6mm distance, to allow acquisition of the whole cell. After acquisition, images
were restored with the Autoquant 3D blind deconvolution module, installed on NIS-
Elements (Nikon Instruments Inc.), using a theoretical PSF.
After restoration, images were loaded in Imaris 4.0 (Bitplane AG, Zurich,
Switzerland), then subtracted of background and used to generate a threshold
based isosurface object group. From each isosurface was calculated the number of
objects and the average object volume expressed as voxel number. At the end of
each quantitation, representative images were obtained as maximum intensity
projection render.
Mathematical analysis of mitochondrial frequency distribution, based on
calculation of circularity factor (C.F.), was performed on best-focused plane, using
the FIJI software (http://ﬁji.sc/).
Immunoblot. Total cell lysates were prepared in RIPA buffer, likewise
separated by SDS-PAGE and the standard immunoblotting procedure was used.
Antibodies used were as follows: rabbit a-Akt, rabbit a-phospho Akt (S473),
mouse a-PARP and rabbit a-Caspase 3 from Cell Signaling (Danvers, MA, USA);
rabbit a-actin from Sigma-Aldrich; goat a-IP3R I from Santa Cruz Biotechnology
(SantaCruz,CA,USA);andmousea-IP3RIIIfromBDBiosciences(FranklinLakes,
NJ, USA).
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